Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Enrolling by invitation
Conditions studied: Prostate Carcinoma
In brief
This trial studies the role of inherited (present at birth) mutations in cancer risk genes such as BRCA2, BRCA1, ATM, CHEK2, and others in relation to prostate cancer. This study may help researchers understand the frequency and importance of inherited mutations in cancer risk genes in patients with prostate cancer and potentially help identify better ways to treat cancer in patients who have a mutation in one of these genes.
Key facts
- Study ID
- NCT04254133
- Run by
- Fred Hutchinson Cancer Center
- People needed
- 1360
- Starts
- 2018-11-30
- Expected to finish
- 2028-08-31
- Last updated by the study team
- 2026-07-21
Who can join
Age: 35 and older, up to 89. Sex: male. Healthy volunteers: accepted.
Where it is running
- Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.